Clinical trial
Open Label Rollover Study of Triumeq in Patients With Amyotrophic Lateral Sclerosis (ALS) Following the Lighthouse II Trial
NCT06658977 is registered in ClinicalTrials.gov with Macquarie University, Australia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open Label Rollover Study of Triumeq in Patients With Amyotrophic Lateral Sclerosis (ALS) Following the Lighthouse II Trial
- Lead sponsor
- Macquarie University, Australia
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- November 15, 2024
- Completion date
- June 3, 2025
- Enrollment
- 12 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.